Niyada Naksuk is a Cardiology physician affiliated with Nebraska Medical Center. OpenAlex indexes 130 publications with 1,191 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Emile @ 42nd St
Omaha, NE 681980001
Telephone
402-559-8888Provider last certified this registry record 3 Dec 2020.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment
- Medtronic, Inc.Program year20244 payments
- Abbott LaboratoriesProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.7%Beta blocker32.4%Metoprolol Succinate52%Metoprolol Tartrate34%Carvedilol14%Part D<11 patientsAntiarrhythmic27.1%Amiodarone Hcl60%Dofetilide23%Flecainide Acetate9%Mexiletine Hcl8%Part D<11 patients+ 2 more classes in this area
Blood & clotting
36.3%Factor Xa inhibitor32.6%Eliquis82%Xarelto18%Part D≥37 patientsDirect thrombin inhibitors3.7%Dabigatran Etexilate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Representation of Women in Atrial Fibrillation Ablation Randomized Controlled Trials: Systematic Review
Journal of the American Heart Association
2025 - Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials
Journal of Cardiovascular Electrophysiology
2024 - Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads
Journal of Interventional Cardiac Electrophysiology
2023 - Prevalence and Impact of Poorly Controlled Modifiable Risk Factors Among Patients Who Underwent Atrial Fibrillation Ablation
The American Journal of Cardiology
2023 - Stellate ganglia stimulation counteracts vagal stimulation by significantly increasing heart rate and blood pressure
Journal of Interventional Cardiac Electrophysiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Andre Kalil, MD
Nebraska Medical Center
Mark Rupp, MD
Nebraska Medical Center
Christopher Kratochvil, MD
Nebraska Medical Center
Dwight Jones, MD
Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”